Citation: | Gao Hongjun, Qiu Minhua, Chen Jibing. Research progress on islet protection and functional maintenance[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 207-212. doi: 10.3969/j.issn.1674-7445.2023.02.005 |
[1] |
CENGIZ E, DANNE T, AHMAD T, et al. ISPAD clinical practice consensus guidelines 2022: insulin treatment in children and adolescents with diabetes[J]. Pediatr Diabetes, 2022, 23(8): 1277-1296. DOI: 10.1111/pedi.13442.
|
[2] |
王宇琴, 朱永星, 冉隆梅, 等. 整合医学模式下2型糖尿病个性化干预的临床效果研究[J]. 实用医学杂志, 2022, 38(18): 2346-2351. DOI: 10.3969/j.issn.1006-5725.2022.18.017.
WANG YQ, ZHU YX, RAN LM, et al. Clinical effect of personalized intervention for patients with type 2 diabetes with holistic integrative medicine[J]. J Pract Med, 2022, 38(18): 2346-2351. DOI: 10.3969/j.issn.1006-5725.2022.18.017.
|
[3] |
张汀滢, 刘桃丽, 胡建国, 等. 中医禁食疗法对超重/肥胖2型糖尿病患者的临床疗效[J]. 中山大学学报(医学科学版), 2022, 43(4): 613-620. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0412.
ZHANG TY, LIU TL, HU JG, et al. Clinical effects of Chinese medicine fasting therapy in overweight/obese type 2 diabetes patients[J]. J Sun Yat-sen Univ (Med Sci), 2022, 43(4): 613-620. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0412.
|
[4] |
傅红兴. 胰岛移植概况[J/CD]. 中华细胞与干细胞杂志(电子版), 2022, 12(4): 0-I. DOI:
FU HX. Overview of islet transplantation[J/CD]. Chin J Cell Stem Cell (Electr Edit), 2022, 12(4): 0-I. DOI:
|
[5] |
KUO CH, LI HY. Pancreatic islet transplantation in type 1 diabetes: current state and future perspectives[J]. J Diabetes Investig, 2023, 14(2): 183-185. DOI: 10.1111/jdi.13942.
|
[6] |
BERNEY T, WASSMER CH, LEBRETON F, et al. From islet of Langerhans transplantation to the bioartificial pancreas[J]. Presse Med, 2022, 51(4): 104139. DOI: 10.1016/j.lpm.2022.104139.
|
[7] |
DANOBEITIA JS, CHLEBECK PJ, SHOKOLENKO I, et al. Novel fusion protein targeting mitochondrial DNA improves pancreatic islet functional potency and islet transplantation outcomes[J]. Cell Transplant, 2017, 26(11): 1742-1754. DOI: 10.1177/0963689717727542.
|
[8] |
NISHIME K, MIYAGI-SHIOHIRA C, KUWAE K, et al. Preservation of pancreas in the University of Wisconsin solution supplemented with AP39 reduces reactive oxygen species production and improves islet graft function[J]. Am J Transplant, 2021, 21(8): 2698-2708. DOI: 10.1111/ajt.16401.
|
[9] |
LEMAIRE F, SIGRIST S, DELPY E, et al. Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas[J]. J Cell Mol Med, 2019, 23(12): 8025-8034. DOI: 10.1111/jcmm.14666.
|
[10] |
SAKAI-YONAHA M, MIYAGI-SHIOHIRA C, KUWAE K, et al. Pancreas preservation in modified histidine-lactobionate solution is superior to that in University of Wisconsin solution for porcine islet isolation[J]. Transplantation, 2022, 106(9): 1770-1776. DOI: 10.1097/TP.0000000000003636.
|
[11] |
KUWAE K, MIYAGI-SHIOHIRA C, HAMADA E, et al. Excellent islet yields after 18-h porcine pancreas preservation by ductal injection, pancreas preservation with MK solution, bottle purification, and islet purification using iodixanol with UW solution and iodixanol with MK solution[J]. J Clin Med, 2019, 8(10): 1561. DOI: 10.3390/jcm8101561.
|
[12] |
OTSUKA R, MIYAGI-SHIOHIRA C, KUWAE K, et al. Pancreas preservation with a neutrophil elastase inhibitor, alvelestat, contributes to improvement of porcine islet isolation and transplantation[J]. J Clin Med, 2022, 11(15): 4290. DOI: 10.3390/jcm11154290.
|
[13] |
NOGUCHI H, MIYAGI-SHIOHIRA C, NAKASHIMA Y, et al. A novel preservation solution containing a JNK inhibitory peptide efficiently improves islet yield for porcine islet isolation[J]. Transplantation, 2019, 103(2): 344-352. DOI: 10.1097/TP.0000000000002555.
|
[14] |
WASSMER CH, PERRIER Q, COMBESCURE C, et al. Impact of ischemia time on islet isolation success and posttransplantation outcomes: a retrospective study of 452 pancreas isolations[J]. Am J Transplant, 2021, 21(4): 1493-1502. DOI: 10.1111/ajt.16320.
|
[15] |
DOPPENBERG JB, LEEMKUIL M, ENGELSE MA, et al. Hypothermic oxygenated machine perfusion of the human pancreas for clinical islet isolation: a prospective feasibility study[J]. Transpl Int, 2021, 34(8): 1397-1407. DOI: 10.1111/tri.13927.
|
[16] |
KESHTKAR S, KAVIANI M, JABBARPOUR Z, et al. Hypoxia-preconditioned Wharton's Jelly-derived mesenchymal stem cells mitigate stress-induced apoptosis and ameliorate human islet survival and function in direct contact coculture system[J]. Stem Cells Int, 2020: 8857457. DOI: 10.1155/2020/8857457.
|
[17] |
GOU W, WANG J, SONG L, et al. Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation[J]. Am J Transplant, 2021, 21(5): 1713-1724. DOI: 10.1111/ajt.16342.
|
[18] |
KESHTKAR S, KAVIANI M, SARVESTANI FS, et al. Exosomes derived from human mesenchymal stem cells preserve mouse islet survival and insulin secretion function[J]. EXCLI J, 2020, 19: 1064-1080. DOI: 10.17179/excli2020-2451.
|
[19] |
CHEN J, CHEN J, CHENG Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation[J]. Stem Cell Res Ther, 2020, 11(1): 97. DOI: 10.1186/s13287-020-01610-0.
|
[20] |
WEN D, PENG Y, LIU D, et al. Mesenchymal stem cell and derived exosome as small RNA carrier and immunomodulator to improve islet transplantation[J]. J Control Release, 2016, 238: 166-175. DOI: 10.1016/j.jconrel.2016.07.044.
|
[21] |
MASUDA Y, VAZIRI ND, LI S, et al. The effect of Nrf2 pathway activation on human pancreatic islet cells[J]. PLoS One, 2015, 10(6): e0131012. DOI: 10.1371/journal.pone.0131012.
|
[22] |
MENGER MM, NALBACH L, ROMA LP, et al. Erythropoietin exposure of isolated pancreatic islets accelerates their revascularization after transplantation[J]. Acta Diabetol, 2021, 58(12): 1637-1647. DOI: 10.1007/s00592-021-01760-4.
|
[23] |
PRUD'HOMME GJ, GLINKA Y, HASILO C, et al. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone[J]. Transplantation, 2013, 96(7): 616-623. DOI: 10.1097/TP.0b013e31829c24be.
|
[24] |
YAMANE K, ANAZAWA T, TADA S, et al. Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response[J]. Sci Rep, 2020, 10(1): 12086. DOI: 10.1038/s41598-020-69009-8.
|
[25] |
STAELS W, VERDONCK Y, HEREMANS Y, et al. Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation[J]. Diabetologia, 2018, 61(8): 1804-1810. DOI: 10.1007/s00125-018-4646-7.
|
[26] |
HU M, HAWTHORNE WJ, YI S, et al. Cellular immune responses in islet xenograft rejection[J]. Front Immunol, 2022, 13: 893985. DOI: 10.3389/fimmu.2022.893985.
|
[27] |
MOU L, SHI G, COOPER DKC, et al. Current topics of relevance to the xenotransplantation of free pig islets[J]. Front Immunol, 2022, 13: 854883. DOI: 10.3389/fimmu.2022.854883.
|
[28] |
HAWTHORNE WJ, SALVARIS EJ, CHEW YV, et al. Xenotransplantation of genetically modified neonatal pig islets cures diabetes in baboons[J]. Front Immunol, 2022, 13: 898948. DOI: 10.3389/fimmu.2022.898948.
|
[29] |
YAO M, DOMOGATSKAYA A, ÅGREN N, et al. Cibinetide protects isolated human islets in a stressful environment and improves engraftment in the perspective of intra portal islet transplantation[J]. Cell Transplant, 2021, 30: 9636897211039739. DOI: 10.1177/09636897211039739.
|
[30] |
LEE CA, DHAWAN A, SMITH RA, et al. Instant blood-mediated inflammatory reaction in hepatocyte transplantation: current status and future perspectives[J]. Cell Transplant, 2016, 25(7): 1227-1236. DOI: 10.3727/096368916X691286.
|
[31] |
YAN LL, YE LP, CHEN YH, et al. The influence of microenvironment on survival of intraportal transplanted islets[J]. Front Immunol, 2022, 13: 849580. DOI: 10.3389/fimmu.2022.849580.
|
[32] |
LIUWANTARA D, CHEW YV, FAVALORO EJ, et al. Characterizing the mechanistic pathways of the instant blood-mediated inflammatory reaction in xenogeneic neonatal islet cell transplantation[J]. Transplant Direct, 2016, 2(6): e77. DOI: 10.1097/TXD.0000000000000590.
|
[33] |
MOLL G, ANKRUM JA, KAMHIEH-MILZ J, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines[J]. Trends Mol Med, 2019, 25(2): 149-163. DOI: 10.1016/j.molmed.2018.12.006.
|
[34] |
LEI J, ZHANG A, DENG H, et al. Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non-human primate[J]. Am J Transplant, 2022, 22(3): 966-972. DOI: 10.1111/ajt.16875.
|
[35] |
VON ZUR-MÜHLEN B, LUNDGREN T, BAYMAN L, et al. Open randomized multicenter study to evaluate safety and efficacy of low molecular weight sulfated dextran in islet transplantation[J]. Transplantation, 2019, 103(3): 630-637. DOI: 10.1097/TP.0000000000002425.
|